TrialTranslational neurodegeneration2023

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.

Burak Yulug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.